Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo Kaluski

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Journal of Clinical Lipidology|July 7, 2019
Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysisSafi U Khan, Haris Riaz, Hammad Rahman, et al.
The American Journal of Cardiology|May 12, 2025
Young Adults Undergoing Percutaneous Coronary Intervention for Myocardial Infarction in the United States, 2011 to 2023Usman Ali Akbar, Mohamad B Taha, Hassaan B Arshad, et al.
Fundamental & Clinical Pharmacology|August 7, 2009
Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?Beth Davison Weatherley, Olga Milo-Cotter, G Michael Felker, et al.
European Journal of Preventive Cardiology|September 19, 2018
Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery diseaseSafi U Khan, Maninder Singh, Ahmad N Lone, et al.
Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.
Journal of Thrombosis and Thrombolysis|April 14, 2020
Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysisSafi U Khan, Muhammad Zia Khan, Zain Ul Abideen Asad, et al.
Pacing and Clinical Electrophysiology : PACE|August 8, 2008
Sinus rhythm restoration after atrial fibrillation: the clinical value of N-terminal pro-BNP measurementsVladimir Danicek, Nick Theodorovich, Shmuel Bar-Chaim, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Acute myocardial infarction with spontaneous reperfusion: clinical characteristics and optimal timing for revascularizationNir Uriel, Gil Moravsky, Alex Blatt, et al.
JACC. Cardiovascular Interventions|February 26, 2011
The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomesMonica Sanchez-Ross, Gerard Oghlakian, James Maher, et al.
Journal of the American Heart Association|March 23, 2019
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-AnalysisSafi U Khan, Hammad Rahman, Victor Okunrintemi, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Journal of Clinical Lipidology|July 7, 2019
Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysisSafi U Khan, Haris Riaz, Hammad Rahman, et al.
The American Journal of Cardiology|May 12, 2025
Young Adults Undergoing Percutaneous Coronary Intervention for Myocardial Infarction in the United States, 2011 to 2023Usman Ali Akbar, Mohamad B Taha, Hassaan B Arshad, et al.
Fundamental & Clinical Pharmacology|August 7, 2009
Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?Beth Davison Weatherley, Olga Milo-Cotter, G Michael Felker, et al.
European Journal of Preventive Cardiology|September 19, 2018
Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery diseaseSafi U Khan, Maninder Singh, Ahmad N Lone, et al.
Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.
Journal of Thrombosis and Thrombolysis|April 14, 2020
Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysisSafi U Khan, Muhammad Zia Khan, Zain Ul Abideen Asad, et al.
Pacing and Clinical Electrophysiology : PACE|August 8, 2008
Sinus rhythm restoration after atrial fibrillation: the clinical value of N-terminal pro-BNP measurementsVladimir Danicek, Nick Theodorovich, Shmuel Bar-Chaim, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Acute myocardial infarction with spontaneous reperfusion: clinical characteristics and optimal timing for revascularizationNir Uriel, Gil Moravsky, Alex Blatt, et al.
JACC. Cardiovascular Interventions|February 26, 2011
The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomesMonica Sanchez-Ross, Gerard Oghlakian, James Maher, et al.
Journal of the American Heart Association|March 23, 2019
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-AnalysisSafi U Khan, Hammad Rahman, Victor Okunrintemi, et al.
Pageof 17